Company

Pioneering non-invasive, early screening of cancer risk in dogs.

Animal Cancer Dx is a team of veterinarians, scientists, and entrepreneurs committed to pioneering early screening of cancer risk in dogs. We have developed a non-invasive, highly accurate, and cost effective cancer detection method with a simple urine sample.

About Animal Cancer Dx

Animal Cancer Dx is a Raleigh-based bioscience company committed to pioneering early screening of cancer risk in dogs with a drop of a urine sample. The company’s patent-pending scientific test, A.C.D. Test™, combines its proprietary metabolomics technology and C. elegans’ highly effective olfactory receptors to detect cancerous VOCs. As a one-of-a-kind multi cancer early screening test, it’s a convenient, non-invasive, cost-effective, and highly accurate cancer screening test available to canine patients.

  • Chan Namgong - CEO & Founder

  • Danny Midkiff, PhD - CSO

  • Jong-Hyuk Kim, DVM, PhD - University of Florida

  • Chuck Miller, DVM - Triangle Veterinary Hospital

  • David Ruslander, DVM, DACVIM (Oncology), DACVR (Radiation Oncology) - BluePearl Pet Hospital

    Pair text with an image to focus on your chosen product, collection, or blog post. Add details on availability, style, or even provide a review.

  • Jacob Berchuck, MD - Dana Farber Cancer Institute

Join the Pioneering Way in Early Cancer Detection for Dogs

If you are eager to incorporate breakthrough innovation into your veterinary practice, we would love to partner with you. Be among the first to offer our pioneering multi-cancer early detection test to your canine patients. Provide your name and email address and we will reach out as we expand our rollout.